The abstracts of the CTAD are available in PDF format, you can download them on
this link
The abstracts of the ICFSR are available in PDF format, you can download them on this link
this link
The abstracts of the ICFSR are available in PDF format, you can download them on this link
this link
Evidence suggests that providing care for a disabled elderly person may have implications for the caregiver’s own health (decreased immunity, hypertension, and depression). The objective of the recent study by F Potier et al (Belgium, Journ Frailty Aging No2, 2018)… Continue Reading →
Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer’s disease. Authors conducted a randomized, double-blind, placebo-controlled, 78-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per… Continue Reading →
The Japanese Association on Sarcopenia and Frailty systematically reviewed all the papers related to clinical questions on the definition, epidemiology, prevention and intervention of sarcopenia and provided the evidence level and recommendations. This is the first clinical guidelines for sarcopenia… Continue Reading →
© 2026 Aging-news
